BioCentury
ARTICLE | Company News

Cambridge Biotech Corp. deal

May 10, 1993 7:00 AM UTC

Cambridge Biotech Corp. (CBCX) Cambridge Biotech Corp. (CBCX) has granted American Cyanamid Co.'s Lederle-Praxis Biologicals division the right to use CBCX's QS-21 adjuvant in several vaccines to tre...